TIVC COO Granted 45,000 Stock Options at $3.32 — Form 4
Michael K. Handley, Chief Operating Officer of Tivic Health Systems (TIVC), received an equity award.
Rhea-AI Filing Summary
Michael K. Handley, Chief Operating Officer of Tivic Health Systems (TIVC), received an equity award. The Form 4 reports an employee stock option to purchase 45,000 shares of common stock with an exercise price of $3.32. The option was granted on 08/06/2025, is exercisable according to the stated vesting schedule and shows 45,000 underlying shares held directly after the grant. The option expires on 08/05/2035 and vests 50% on the first anniversary, with the remaining 50% in twelve equal quarterly installments so the award fully vests by year four.
Positive
- Officer received an equity grant of 45,000 options, aligning management incentives with shareholders
- Vesting schedule is time-based (50% at first anniversary, remainder over 12 quarterly installments), supporting retention
Negative
- None.
Insights
TL;DR: A standard executive option grant aligns the COO with shareholders but raises routine reporting obligations.
The Form 4 documents an option award to the Chief Operating Officer for 45,000 shares at $3.32 per share, reported as a direct holding. The grant includes a common multi-year vesting schedule that ties pay to future service and potential share-price performance. From a governance perspective, this is a routine compensation action; disclosure is required and was provided. Absent other context on dilution or total outstanding equity, this single grant appears procedural rather than materially transformative.
TL;DR: The award is a typical retention/incentive instrument; materiality depends on company capitalization not included here.
The instrument is an employee stock option with a $3.32 exercise price and a ten-year term expiring 08/05/2035, covering 45,000 shares with a time-based vesting schedule (50% at year one, balance over 12 quarters). This structure is conventional for executive long-term incentives. Without details on total shares outstanding or prior grants, we cannot quantify dilution or cost, so the item should be treated as routine compensation disclosure rather than a major capital event.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Employee Stock Option (Right to Purchase) | 45,000 | $0.00 | $0.00 |
Footnotes (1)
- F1. The stock option vests as follows: (i) 50% upon the first anniversary of the grant date, and (ii) the remaining 50% in a series of twelve (12) successive equal quarterly installments, rounded downward to the nearest whole share, measured from the first anniversary of the grant date, such that 100% of the stock option will be vested upon the fourth anniversary of the grant date.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Michael K. Handley report for TIVC?
What is the vesting schedule for the TIVC option reported on Form 4?
When does the option for the TIVC grant expire?
Who signed the Form 4 filing for this TIVC transaction?
AI-generated analysis. How Rhea-AI works. Not financial advice.